Ending the HIV Epidemic in the Deep South: Updates on TAG’s Southern Initiative
A message from Treatment Action Group
Now is the time to end the HIV/AIDS epidemic in America’s southern states.
Over the past four years, innovative Ending the Epidemic (EtE) plans have emerged in several jurisdictions across the nation following New York’s 2014 announcement that it will end the state’s HIV epidemic by 2020. While most of these plans have been announced for cities, counties, and states outside of the South, community advocates in Fulton County, Georgia blazed their own trail in 2014, working with local government to establish a task force and develop an EtE plan. Houston community advocates led a process to develop their own plan in partnership with the Houston Health Department, ultimately launching their Roadmap to Ending the HIV Epidemic in Houston in December of 2016.
One thing is abundantly clear: We can’t end the epidemic in the U.S. if we don’t end it in the South.
Read more »
Now Accepting Applications for the 2018 Prevention Internship Program
A message from The U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP)
Greetings!
The U.S. Department of Health and Human Services (HHS) Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) is accepting applications for the 2018 Prevention Internship Program.
The Prevention Internship Program, a component of SAMHSA/CSAP’s Prevention Fellowship Program, invites qualified individuals with strong interest in substance abuse prevention and behavioral health, for a 5-month paid internship in participating Tribes and Tribal Organizations throughout the United States. (Visit the application Web site at www.seiservices.com/SAMHSA/csap/preventionfellowship for a list of participating locations.)
Read more »
Call for Abstracts: Global Hepatitis Summit 2018
16th International Symposium on Viral Hepatitis and Liver Disease Global Hepatitis Summit
Toronto, Canada, June 14-17, 2018
Congress registration will open October 2017.
Read more »
UsAgainstAlzheimer's National Summit 2017
On Wednesday, October 4, 2017, UsAgainstAlzheimer's held a National Summit in Washington D.C. Veronica Miller, PhD, the Executive Director of the Forum was one of the panelists.
The Opening Session Panelists from left to right: Nancy Brinker (founder of Susan G Komen), The other panelists are Rita Carreon (hidden) – Institute for Hispanic Health UnidosUS, Wade Henderson (Leadership Conference on Civil and Human Rights), Veronica Miller (Forum for Collaborative Research), Isabell Sawhill (Brookings Institution/ National Campaign to Prevent Teen and unplanned pregnancy) & Mike McMurry (Former White House Secretary)
On behalf of UsAgainstAlzheimer’s and all those who attended our National Summit events last week, I write to thank you for the perspectives and insights you shared with all of us as a panelist for our opening session, Growing the Alzheimer's Movement: Learning from Others.
Read more »
Challenge Contests for Health: A Call for Entries
A message from the Social Entrepreneurship for Sexual Health (SESH)
Deadline to submit: 10 November 2017
The purpose of this call is to gather information related to health challenge contests – defined as open calls to solicit community input in order to improve public health. Descriptions of case studies, experiences organizing contests, and evaluation examples are being solicited. These cases will be reviewed by a panel based on clarity of model, effectiveness, promotion of equity, and potential for learning. Exceptional cases will be included in a global toolkit on challenge contests for health.
Read more »
Viral Hepatitis Updates from the HHS Office of HIV/AIDS and Infectious Disease Policy
A message from The Office of HIV/AIDS and Infectious Disease Policy
Richard Wolitski, PhD and Corinna Dan, RN, MPH Office of HIV/AIDS and Infectious Disease Policy U.S. Department of Health and Human Services
The Office of HIV/AIDS and Infectious Disease Policy (OHAIDP), in collaboration with the Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), and the HHS Office of Minority Health (OMH), is pleased to announce the launch of a new joint initiative: the Hepatitis C Medicaid Affinity Group. The Hepatitis C Medicaid Affinity Group aims to increase the number and percentage of Medicaid patients diagnosed with hepatitis C virus (HCV) infection that are successfully treated and cured. Read about this new initiative.
Read more »
PSC Partners Interviews Veronica Miller
At the PSC Partners Seeking a Cure 2017 Annual Conference, PSC Partners interviewed several experts, which including the Forum's Executive Director, Veronica Miller, PhD. In this interview, Dr. Miller discusses her background as a clinical researcher, virologist and immunologist and highlights the importance of the PSC Forum. She states,"the aim of the project is to bring all of the different scientists together, from all the different stakeholders to come to a consensus on what it takes to develop new diagnostics and drugs and establish enough collaboration to make the whole system more efficient." PSC is the Forum's most recent project.
For more information on PSC Partners Seeking a Cure and to learn more about primary sclerosing cholangitis, please visit their website below:
http://pscpartners.org/awareness-week/
CDER Biomarker Qualification Program Update
A message from Christopher Leptak at the Food and Drug Administration, Office of New Drugs
Under the 21st Century Cures Act enacted on December 13, 2016, new section 507 (“Qualification of Drug Development Tools”) was added to the Federal Food, Drug, and Cosmetic Act (FD&C Act). Although CDER had previously implemented a biomarker qualification program (or “legacy” program), section 507 establishes an updated, multi-stage process for DDT qualification.
Read more »
Press Release: National Academies of Sciences, Engineering, and Medicine
A Press Release from the National Academies of Sciences, Engineering, and Medicine.
U.S. Could Be Rid of Hepatitis B and C as Public Health Problems, Preventing Nearly 90,000 Deaths by 2030, With Better Attention to Prevention, Screening, Treatment, and Creative Financing for Medicines
WASHINGTON – Hepatitis B and C kill more than 20,000 people every year in the United States. A new report from the National Academies of Sciences, Engineering, and Medicine presents a strategy to eliminate these diseases as serious public health problems and prevent nearly 90,000 deaths by 2030.
“Viral hepatitis is simply not a sufficient priority in the United States,” said Brian Strom, chair of the committee that carried out the study and chancellor and university professor, Rutgers Biomedical and Sciences, Rutgers University, Newark, N.J. “Despite being the seventh leading cause of death in the world – and killing more people every year than HIV, road traffic accidents, or diabetes – viral hepatitis accounts for less than 1 percent of the National Institutes of Health research budget.”
Read more »
International AIDS Society (IAS) Annual Letter
A message from IAS (International AIDS Society).
Dear IAS Members and Partners
As 2017 begins, our community is anxious and concerned. Political and societal changes continue to upend our expectations and generate uncertainty about what is ahead of us. We worry about human rights, the plight of refugees and migrants, progress towards gender equality, and the strength of our commitment to each other as human beings.
Deeply wrapped up in all of this is our fight against HIV – a disease that has shown itself adept at exploiting the very changes that seem to be dominating our world.
As corners of the planet shift towards nationalism and xenophobia, we wonder where the future of our global cause lies. Is the progress we have made against the greatest pandemic of our time slipping through our hands?
Read more »
|
|